Status:

COMPLETED

A Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility

Lead Sponsor:

Isifer AB

Collaborating Sponsors:

Karolinska Institutet

Conditions:

Infertility

Eligibility:

FEMALE

20-40 years

Phase:

PHASE2

Brief Summary

The study tested the hypothesis that a pertubation with a lidocain solution will enhance pregnancy rate.

Detailed Description

In a prospective study, patients were randomized during a clomiphene citrate stimulated cycle to either pertubation with low-dose lidocain or no pertubation before insemination.

Eligibility Criteria

Inclusion

  • Female,
  • 20-40 years of age,
  • If presence of peritoneal endometriosis they must be of minimal or mild without adhesions (verified by laparoscopy),
  • Normal menstruation cycle,
  • Male partner 20-70 years of age,
  • Male partner,
  • Normal sperm sample within 5 years (\>20x106/mL, total sperm count \>30x106, normal morphology 5%),
  • Duration of infertility more than one year,
  • Signed informed consent

Exclusion

  • Treatment with NSAID, corticosteroids or other drugs, which can cause an increased risk of infection,
  • Clinical signs of PID,
  • Known hypersensitivity to local anesthetics,
  • Non-patent fallopian tubes,
  • Pathological uterine cavity,
  • Pathological PCT, myoma \> 2 cm diameter,
  • Any disease or laboratory finding considered of importance by the investigator not to include the patient

Key Trial Info

Start Date :

September 1 2003

Trial Type :

INTERVENTIONAL

End Date :

September 1 2006

Estimated Enrollment :

330 Patients enrolled

Trial Details

Trial ID

NCT00449449

Start Date

September 1 2003

End Date

September 1 2006

Last Update

March 20 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

1. Department of Obstetrics and Gynecology, Karolinska University Hospital at Huddinge

Stockholm, Stockholm County, Sweden, 141 86